Crockett Nigel 4

Accession 0001209191-21-046700

CIK 0001761612other

View on SEC.gov Company Profile

Filed

Jul 13, 8:00 PM ET

Accepted

Jul 14, 6:47 PM ET

Size

31.9 KB

Accession

0001209191-21-046700

Insider Transaction Report

Form 4

Period: 2021-07-12

BICYCLE THERAPEUTICS plcBCYC

Crockett Nigel

CHIEF BUSINESS OFFICER

Transactions

Exercise/Conversion
Ordinary Shares
2021-07-13$11.66/sh+40,426$471,367→ 40,426 total
Exercise/Conversion
Ordinary Shares
2021-07-12$11.66/sh+4,331$50,499→ 4,331 total
Exercise/Conversion
Ordinary Shares
2021-07-12$15.36/sh+974$14,961→ 7,028 total
Sale
Ordinary Shares
2021-07-12$32.03/sh−7,028$225,107→ 0 total
Exercise/Conversion
Employee Stock Option (right to buy)
2021-07-12−1,723→ 58,006 total
Exercise: $9.82Exp: 2030-01-02→ Ordinary Shares (1,723 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2021-07-13−19,256→ 38,750 total
Exercise: $9.82Exp: 2030-01-02→ Ordinary Shares (19,256 underlying)
Sale
Ordinary Shares
2021-07-13$32.41/sh−69,580$2,255,088→ 3,121 total
Exercise/Conversion
Ordinary Shares
2021-07-13$15.36/sh+13,019$199,972→ 72,701 total
Exercise/Conversion
Employee Stock Option (right to buy)
2021-07-13−13,019→ 30,764 total
Exercise: $15.36Exp: 2030-02-21→ Ordinary Shares (13,019 underlying)
Exercise/Conversion
Ordinary Shares
2021-07-12$9.82/sh+1,723$16,920→ 6,054 total
Exercise/Conversion
Ordinary Shares
2021-07-13$9.82/sh+19,256$189,094→ 59,682 total
Exercise/Conversion
Employee Stock Option (right to buy)
2021-07-12−4,331→ 103,086 total
Exercise: $11.66Exp: 2029-09-26→ Ordinary Shares (4,331 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2021-07-12−974→ 43,783 total
Exercise: $15.36Exp: 2030-02-21→ Ordinary Shares (974 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2021-07-13−40,426→ 62,660 total
Exercise: $11.66Exp: 2029-09-26→ Ordinary Shares (40,426 underlying)
Sale
Ordinary Shares
2021-07-13$33.09/sh−3,121$103,274→ 0 total

Footnotes (7)

[F1]Shares sold pursuant to a Rule 10b5-1 trading plan.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.26 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4).
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.99 inclusive.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.50 inclusive.
[F5]25% of the shares underlying this option shall vest on September 26, 2020, and the remaining shall vest in 36 equal monthly installments.
[F6]This option shall vest one-fourth (1/4) of the total number of shares under option on January 2, 2021 and the remaining shares in 36 equal monthly installments at the end of each calendar month thereafter.
[F7]This option shall vest one-fourth (1/4) of the total number of shares under option on February 21, 2021 and the remaining shares in 36 equal monthly installments at the end of each calendar month thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

BICYCLE THERAPEUTICS plc

CIK 0001761612

→

Entity typeother

Related Parties

filerCIK 0001788580

Filing Metadata

Form type: 4
Filed: Jul 13, 8:00 PM ET
Accepted: Jul 14, 6:47 PM ET
Size: 31.9 KB

View on SEC.gov